Ticker > Company >

Wockhardt share price

Wockhardt Ltd.

NSE: WOCKPHARMA BSE: 532300 SECTOR: Pharmaceuticals & Drugs  110k   227   43

1,655.85
-62.60 (-3.64%)
BSE: 26 Jun 04:01 PM

Price Summary

Today's High

₹ 1,777.95

Today's Low

₹ 1,603.55

52 Week High

₹ 1,870

52 Week Low

₹ 630.10

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

26,905.17 Cr.

Enterprise Value

28,209.17 Cr.

No. of Shares

16.25 Cr.

P/E

0

P/B

9.74

Face Value

₹ 5

Div. Yield

0 %

Book Value (TTM)

₹  170.06

CASH

486 Cr.

DEBT

1,790 Cr.

Promoter Holding

49.09 %

EPS (TTM)

₹  -0.74

Sales Growth

7.65%

ROE

-23.98 %

ROCE

-5.32%

Profit Growth

9.44 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.65%
3 Year5.35%
5 Year-5.82%

Profit Growth

1 Year9.44%
3 Year-189.28%
5 Year-225.82%

ROE%

1 Year-23.98%
3 Year-18.37%
5 Year-23.22%

ROCE %

1 Year-5.32%
3 Year-3.57%
5 Year-6.68%

Debt/Equity

1.00

Price to Cash Flow

143.11

Interest Cover Ratio

-0.78

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 49.09 18.24
Dec 2024 49.09 16.98
Sep 2024 51.99 33.64
Jun 2024 51.99 37.47
Mar 2024 51.60 52.90
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -165.79 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 8.94.

 Limitations

  • The company has shown a poor profit growth of -2.62% for the Past 3 years.
  • The company has shown a poor revenue growth of 5.35% for the Past 3 years.
  • Company has a poor ROE of -18.37% over the past 3 years.
  • Company has a poor ROCE of -3.57% over the past 3 years
  • Company has low Interest coverage ratio of -0.78.
  • Company has contingent liabilities of 882.46 Cr.
  • Tax rate is low at 0.
  • The company has a low EBITDA margin of -2.83% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 79.77.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 355 352 370 325 355
Total Expenditure 401 272 321 263 249
Operating Profit -46 80 49 62 106
Other Income 24 27 11 6 14
Interest 59 58 53 48 40
Depreciation 45 43 43 42 40
Exceptional Items 0 0 0 0 0
Profit Before Tax -126 6 -36 -22 40
Tax 0 0 0 0 0
Profit After Tax -126 6 -36 -22 40
Adjusted EPS (Rs) -8.18 0.39 -2.34 -1.36 2.47

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 890.06 987 1,372 1,072 1,154
Total Expenditure 1,066 1,125 1,150 1,002 1,190
Operating Profit -175.94 -138 222 70 -36
Other Income 85.82 41 38 67 41
Interest 220.17 200 273 229 237
Depreciation 173.39 184 171 186 176
Exceptional Items 0 -142 0 -235 -14
Profit Before Tax -483.68 -623 -184 -513 -422
Tax -158 -231 -44 -47 0
Net Profit -231.12 593 -140 -466 -422
Adjusted EPS (Rs.) -27.10 -32.84 -9.72 -32.36 -27.40

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 55.37 55 72 72 77
Total Reserves 939.25 1,551 2,140 1,681 1,719
Borrowings 519.50 259 146 12 891
Other N/C liabilities 692.74 272 187 91 43
Current liabilities 2,305.25 2,603 3,049 2,626 1,888
Total Liabilities 4,512.11 4,740 5,594 4,482 4,618
Assets
Net Block 2,044.35 1,684 1,828 1,625 1,449
Capital WIP 305.29 307 69 56 56
Intangible WIP 0 409 756 767 777
Investments 297.27 297 297 297 297
Loans & Advances 202.02 203 238 245 243
Other N/C Assets 85.92 145 162 196 128
Current Assets 1,577.26 1,695 2,244 1,296 1,668
Total Assets 4,512.11 4,740 5,594 4,482 4,618
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -338.32 861 -184 -513 -422
Adjustment 355.96 -995 410 433 494
Changes in Assets & Liabilities 204.37 -318 -240 156 116
Tax Paid -0.50 -111 -79 -5 0
Operating Cash Flow 221.51 -563 -93 71 188
Investing Cash Flow -16.15 1,014 -244 -3 -75
Financing Cash Flow -273.97 -480 430 -236 346
Net Cash Flow -68.61 -29 93 -168 459

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 51.60 51.99 51.99 49.09 49.09
ananke trustee company pr... 2.57 2.66 2.66 2.52 2.52
callirhoe trustee company... 1.73 2.03 2.03 1.92 2.50
habil f khorakiwala 0.39 0.39 0.39 0.37 0.37
huzaifa habil khorakiwala... 0.18 0.18 0.18 0.17 0.17
murtaza habil khorakiwala... 0.19 0.19 0.19 0.18 0.18
pasithee trustee company ... 3.30 3.30 3.30 3.12 3.12
themisto trustee company ... 42.61 42.61 42.61 40.24 40.23
callirhoe trustee company... 0.61 0.61 0.61 0.58 -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 48.40 48.01 48.01 50.91 50.91
3p india equity fund 1 - - 1.47 1.39 1.62
hdfc large and mid cap fu... - - - 1.12 1.19
hsbc small cap fund - - - - 1.01
investor education and pr... 0.20 - 0.20 - 0.19
llp 0.58 0.47 0.77 - 0.75
rekha jhunjhunwala 1.89 1.89 1.85 - 1.75
tata mutual fund - tata s... - - - 1.09 1.64
estate of late mr. rakesh... - - - 1.75 -
icici prudential elss tax... - - - 1.06 -
investor education and pr... - 0.20 - 0.19 -
llp - - - 0.73 -
icici prudential equity &... 1.26 1.27 1.27 - -

Annual Reports

Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
Credit FITCH
Credit CARE
Credit CARE
Credit CARE
Credit CARE RATINGS
Credit FITCH
Credit FITCH
Credit INDIA RATINGS & RESEARCH
TYPE AGENCY Link
No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
Presentation Q4FY20
Presentation Q3FY23
Presentation Q3FY22
Presentation Q3FY20
Presentation Q2FY21
Presentation Q1FY21
Presentation 9MFY24

Company News

Wockhardt Stock Price Analysis and Quick Research Report. Is Wockhardt an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Wockhardt and its performance over the period of time. Wockhardt stock price today is Rs 1,655.70.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Wockhardt cash from the operating activity was Rs 188 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Wockhardt has a Debt to Equity ratio of 1.00 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Wockhardt , the EPS growth was 15.32 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Wockhardt has OPM of -3.12 % which is a bad sign for profitability.
     
  • ROE: Wockhardt have a poor ROE of -23.98 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Wockhardt is Rs 1,655.70. One can use valuation calculators of ticker to know if Wockhardt share price is undervalued or overvalued.
Last Updated on:
Brief about Wockhardt
X